Neimeth International Pharmaceuticals Community

Neimeth International Pharmaceuticals Plc – Capital Raise Signals a Strategic Reset and Growth Potential Neimeth International Pharmaceuticals Plc has entered a new growth phase following shareholder approval to raise up to ₦20 billion in fresh capital through diverse mechanisms including public offering, rights issue, private placement, and strategic allotment. This move coincides with efforts to restructure its balance sheet and restore profitability, triggering increased investor confidence and a share price rally from ₦3.70 to ₦5.94 within a week.